|
0
|
|
Cardiovascular Magnetic Resonance to Guide Defibrillator Implantation for LVEF of 36% to 50%: The CMR GUIDE Randomized Clinical Trial.
(jamanetwork.com)
|
Selvanayagam JB
…
Ganesan A
JAMA
2026-08-28
|
#cardiomyopathy
#arrhythmia
#imaging
#randomized-trial
#prevention
|
|
0
|
|
Electrocardiogram-Based Deep Learning to Prioritize Testing for Transthyretin Amyloid Cardiomyopathy.
(jamanetwork.com)
|
Croon PM
…
Khera R
JAMA
2026-08-28
|
#deep learning
#amyloid
#cardiomyopathy
#diagnosis
#electrocardiography
|
|
0
|
|
Eplontersen for Transthyretin Amyloid Cardiomyopathy.
(nejm.org)
|
Fontana M
…
Maurer MS
New England Journal of Medicine
2026-08-28
|
#amyloid
#cardiomyopathy
#clinical trial
#oligonucleotide
#therapeutics
|
|
0
|
|
Aficamten for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.
(nejm.org)
|
Masri A
…
Ho CY
New England Journal of Medicine
2026-08-28
|
#cardiomyopathy
#clinical trial
#cardiac
#pharmacotherapy
|
|
0
|
|
FASN-mediated de novo lipogenesis promotes ceramide accumulation and myocardial damage in arrhythmogenic cardiomyopathy.
(linkinghub.elsevier.com)
|
Liu Z
…
Hu S
iScience
2026-08-28
|
#cardiomyopathy
#lipogenesis
#lipotoxicity
#lipidomics
#desmosomal
|